Awarded a partially refundable grant for research project: Bluespe
Tue, 31/07/2018 - 00:00
1 minAwarded a partially refundable grant for research project: Bluespe
Related
ROVI REPORTS OPERATING REVENUE GROWTH OF 31% AND NET PROFIT GROWTH OF 58%
Operating revenue increased by 31% to 380.4...
3 min
27/07/2022
Madrid, 19th July 2022
The European Investment Bank (EIB) is providing Laboratorios Farmacéuticos Rovi (ROVI) with a new EUR 50 million...
4 min
19/07/2022
ROVI REPORTS OPERATING REVENUE GROWTH OF 57% AND NET PROFIT GROWTH OF 123%
• Operating revenue increased by 57% to 205.6 million euros...
2 min
11/05/2022
Awarded a partially refundable grant for research project: Bluespe